SHILPA MEDICARE

manufacturing-news

Shilpa Medicare Receives SEC Approval for OERIS Extended-Release Injection

MM Desk 15 September, 2026

Shilpa Medicare Limited (BSE: 530549 | NSE: SHILPAMED) has received final approval from the Subject

manufacturing-news

Shilpa Medicare Partners with Gate2Brain to Advance Innovative Brain Cancer Therapy

MM Desk 9 June, 2026

Shilpa Biocare Pvt Ltd, a subsidiary of Shilpa Medicare Limited, has entered into a strategic